Riot Blockchain Inc., formerly Bioptix, Inc., intends to gain exposure to the block chain ecosystem through targeted investments in the sector, with a primary focus on the bitcoin and Ethereum blockchains. The Company also provides Enhanced Surface Plasmon Resonance (SPR) platform for the detection of molecular interactions. The Company’s line of Enhanced SPR instruments are designed to increase the flexibility and reliability of SPR. Its SPR biosensors shed light on important binding parameters that are crucial for determining whether a biologic or small molecule drug efficacious in humans and at what dose a drug should be administered. Its technology is an ultra-sensitive detection platform. The design of its SPR spectrometers allows discrete areas within the sample cell to be interrogated simultaneously. Its biosensors provide information on kinetic processes, binding affinities, analyte concentrations and real-time molecule detection.